Neuroderm, Ltd. IPO Research Information

Neuroderm, Ltd. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Neuroderm, Ltd., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Neuroderm, Ltd.	NDRM - NASDAQ	$13.00-$16.00	$10.00	$9.45	4.5 million	11/14/2014
Underwriter(s): Jefferies, Cowen & Co.
Co-Manager(s): Oppenheimer Co., Roth Capital Partners
Industry: Health Care
Filing(s): Filed 2014-09-15 Terms Added 2014-11-03

Neuroderm, Ltd. Quote & Chart - Click for current quote - NDRM

About Neuroderm, Ltd. (adapted from Neuroderm, Ltd. prospectus):
They are a clinical stage pharmaceutical company developing next-generation treatments for central nervous system, or CNS, disorders through proprietary formulations based on existing drugs that are intended to make a significant difference in patients lives.

This description is adapted from Neuroderm prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Neuroderm "NDRM" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.